- Faster insulin process
stabilisation in children with diabetes: 64% of a group of diabetic children
experienced a 2-3-day faster process stabilisation
than the children in the control group
- Shorter stays in
hospital for dysfunctional juvenile uterine haemorrhage: the girls could
be released from hospital an average of 2 days earlier than the girls in
the control group; in 75% of the girls healing actually occurred twice as
fast as in the control group, and they could already go home 3 days earlier
- Healing-inducing
effects in blood formation
following gynaecological surgery: at the end of the treatment only 26% of
the results indicated anaemia, compared to 39% in the control group
- Faster normalisation
of the kidney function:
breakdown of the protein content in the urine of pregnant women treated
for OPH syndrome.
The protein content of the urine was broken down within 4-5 days, significantly
faster than in the control group
- Faster adaptability
to the new condition in children with diabetes who received insulin for
the first time: 64% adapted more quickly to their new condition than those
in the control group
- Faster normalisation
of high blood pressure in pregnant women than in a control group receiving
hypotensive and sedative medicine
- Dispersion of the
clinical risk characteristics in pregnant women with health disorders which
threatened to lead to miscarriage: already after a 2-3 days’ treatment
there were no longer any clinical risk characteristics in 60% of the women
patients.
In the time from the fifth to the seventh day, these also disappeared in
the remaining 40% of patients.
In the control group the clinical risk characteristics in 70% of the women
had disappeared after 7-10 days’ treatment. However, in 30% they remained
- Shorter stays in
hospital: a 35% faster recovery in pregnant women with health disorders
which
threatened to lead to miscarriage than those in the control group
- Faster recovery
in high-risk pregnancies with a OPH syndrome: in this group treatment could
be completed 14% faster than in the control group
For this
indication please use the programme:
Vital
Energy
For
more information please visit: 
For
the complete studies please visit:
©
A A R E D I T I O N I N T E R N A T I
O N A L 2001
